A Unique Opportunity to Strengthen Existing Relationships & Form New Connections
Within the Small Molecule & Covalent Drug Discovery Space
We partner with cutting-edge service providers with capabilities in hit screening, chemoproteomics, computational biology tools, and assay development for small molecule drug developers with the goal to unite the industry to overcome existing challenges in this emerging space and unlock the potential of covalent drugs.
If you have relevant capabilities and are looking to collaborate with the key decision makers in the small molecule space, contact us to promote your capabilities through a bespoke commercial package.
Email email@example.com to request more information on our partnership opportunities.
Benefit from Market Intelligence:
Expand your networking horizons by meeting 80+ covalent drug experts across 3-days of networking, data sharing, and case-study analysis to match your solutions to the market
Meet & Network with Industry Pioneers:
Promote your brand to powerhouses and newcomers alike, including Amgen, Novartis, Revolution Medicines, Covant Therapeutics, Scorpion Therapeutics, Totus Medicines & many more
Raise Brand Awareness &
Generate Commercial Collaborations:
Conduct meaningful interactions and generate commercial opportunities with 7+ hours of built-in networking time with CXOs, VPs, and Directors of Discovery, Medicinal and Biological Chemistry